Skip to content

Odyssey Health, Inc.: 10-Q filed 2020-03-12

What Odyssey Health, Inc. reported in its quarterly report filed 2020-03-12 (fiscal Q2 2020): 28 published measures, 76 facts as tagged in accession 0001683168-20-000778.

This filing

Form
10-Q (quarterly report)
Filed
2020-03-12
Fiscal period
fiscal Q2 2020
Accession
0001683168-20-000778 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Odyssey Health, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2020-01-3122,341,190USD
At 2019-07-3123,661,015USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2020-01-311,478,828USD
At 2019-07-311,274,203USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2020-01-3120,862,362USD
At 2019-07-3122,386,812USD
At 2019-01-31-923,031USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2020-01-312,759USD
At 2019-07-31167,095USD
At 2019-01-31629USD
At 2018-07-31390USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2019-11-01 to 2020-01-31-1,146,610USD92
2019-08-01 to 2020-01-31-3,110,067USD184
2018-11-01 to 2019-01-31-106,472USD92
2018-08-01 to 2019-01-31-175,968USD184

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2019-08-01 to 2020-01-31-314,336USD184
2018-08-01 to 2019-01-31-18,761USD184

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2019-11-01 to 2020-01-310USD92
2019-08-01 to 2020-01-310USD184
2018-11-01 to 2019-01-310USD92
2018-08-01 to 2019-01-310USD184

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2019-08-01 to 2020-01-31150,000USD184
2018-08-01 to 2019-01-3119,000USD184

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

PeriodValueUnitDays
2019-08-01 to 2020-01-310USD184
2018-08-01 to 2019-01-310USD184

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2020-01-31-4,631,369USD
At 2019-07-31-1,521,302USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2019-11-01 to 2020-01-3187,123,009shares92
2019-08-01 to 2020-01-3187,167,772shares184
2018-11-01 to 2019-01-3164,703,372shares92
2018-08-01 to 2019-01-3163,058,686shares184

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2019-11-01 to 2020-01-31-0.01USD/shares92
2019-08-01 to 2020-01-31-0.04USD/shares184
2018-11-01 to 2019-01-310USD/shares92
2018-08-01 to 2019-01-310USD/shares184

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

PeriodValueUnitDays
At 2020-01-311,241USD
At 2019-07-311,517USD

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2019-08-01 to 2020-01-311,500,187USD184
2018-08-01 to 2019-01-3147,000USD184

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2019-11-01 to 2020-01-31-1,045,419USD92
2019-08-01 to 2020-01-31-2,914,985USD184
2018-11-01 to 2019-01-31-89,763USD92
2018-08-01 to 2019-01-31-142,167USD184

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

PeriodValueUnitDays
At 2020-01-31297,888USD
At 2019-07-31519,928USD

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2019-11-01 to 2020-01-31101,191USD92
2019-08-01 to 2020-01-31195,082USD184
2018-11-01 to 2019-01-3116,709USD92
2018-08-01 to 2019-01-3133,801USD184

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2020-01-3130,128USD
At 2019-07-3147,743USD

Net finite-lived intangible assets

Finite-lived intangible assets after amortization. This excludes goodwill and should not be combined with indefinite-lived intangible assets without checking scope.

PeriodValueUnitDays
At 2020-01-3122,042,061USD

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2019-11-01 to 2020-01-310USD92
2019-08-01 to 2020-01-310USD184
2018-11-01 to 2019-01-310USD92
2018-08-01 to 2019-01-310USD184

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2019-11-01 to 2020-01-310USD92
2019-08-01 to 2020-01-310USD184
2018-11-01 to 2019-01-310USD92
2018-08-01 to 2019-01-310USD184

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2020-01-3187,190,400shares
At 2019-07-3186,990,400shares

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

PeriodValueUnitDays
At 2020-01-3122,042,061USD
At 2019-07-3123,139,570USD

Net deferred tax assets

Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.

PeriodValueUnitDays
At 2020-01-31913,361USD
At 2019-07-31260,247USD

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

PeriodValueUnitDays
2019-11-01 to 2020-01-311,045,419USD92
2019-08-01 to 2020-01-312,914,985USD184
2018-11-01 to 2019-01-3189,763USD92
2018-08-01 to 2019-01-31142,167USD184

Depreciation expense

Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.

PeriodValueUnitDays
2019-08-01 to 2020-01-31276USD184
2018-08-01 to 2019-01-31276USD184

Amortization of intangible assets

Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.

PeriodValueUnitDays
2019-08-01 to 2020-01-311,097,510USD184
2018-08-01 to 2019-01-315,000USD184

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2019-08-01 to 2020-01-31-17,615USD184
2018-08-01 to 2019-01-312,380USD184

Inspect the source

Entity
Odyssey Health, Inc. / CIK 0001626644
Captured
2026-09-19T11:19:48.570Z
SEC response SHA-256
1be33e1ca79fd1e1d5399b519a2ef141b4c1191380216b92c135e07a22902f7b

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001626644.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))